StockNote
VMD
Vimedimex Medical Pharmaceutical Joint Stock Company (VMD), formerly known as a State-owned enterprise, was established in 1984. Since 2006, the Company has moved to operate under the model of a joint stock company. The company operates mainly in the field of pharmaceutical research, production and distribution. Currently, the company is operating Vimedimex 2 factory with 3 production workshops meeting GMP-EU standards. The Company's product distribution system is distributed throughout the southern, southwestern and northern provinces (mainly in the south in the southwest such as Ho Chi Minh City, Binh Duong, Can Tho, Tay Ninh and the north are now available in Hanoi). In 2010, VMD was officially traded at the Ho Chi Minh City Stock Exchange (hose).
VMD currently has a market capitalization of roughly VND 213 billion, placing it in the small-cap group on the Vietnamese stock market. Its current P/E of 5,3x is 55% below its own 8-year average (11,7x), suggesting the stock is trading cheaper than its historical norm. P/B stands at 0,6x, 36% below its multi-year average of 0,9x. Return on equity (ROE) is at 9,4%, up from 5,4% the year before. Its debt-to-equity ratio of 0x is low, reflecting a conservative capital structure. In 2025, revenue fell 35% year-on-year while after-tax profit grew 80%.
This note is generated automatically from the stock's real financial data, for reference only — not investment advice.
Revenue & Profit
Unit: VND billion. Growth (%) vs. previous period.
Market Cap
Unit: VND billion. Year-end values; current year uses latest session.
Debt / Equity
Unit: x. Financial debt over shareholders' equity.
Data aggregated from cafef.vn and VNDirect, for reference only, not investment advice.